CWChen Wang

Chen Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chen Wang has a total of 125 co-authors. Here are the top co-authors by number of shared publications:

  • Yibo Yao

    Department of Proctology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    6 shared publications
  • Jin-Gen Lu

    Department of Proctology, Longhua Hospital affiliated to Shanghai University of TCM, Shanghai, People’s Republic of China

    4 shared publications
  • Yuanting Mao

    Clinical Medical College, Jiangxi University of Chinese Medicine

    4 shared publications
  • Bo Wang

    Shanghai Shumiao Health Cloud Co. Ltd, Shanghai, China

    3 shared publications
  • Hong-Tao Liang

    Department of Proctology, Longhua Hospital affiliated to Shanghai University of TCM, Shanghai, People’s Republic of China

    3 shared publications
  • Jiawen Wang

    Department of Anorectal Surgery, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    3 shared publications

Latest Publications

  • Open Access

    Mitochondrial quality control and intestinal barrier dysfunction in inflammatory bowel disease: knowledge mapping and translational perspectives on traditional Chinese medicine-derived bioactive compounds

    by Yuanting Mao, Guopei Zhou, Xiaojian Li, Leichang Zhang, Chen Wang

    Background: Inflammatory bowel disease is a chronic relapsing intestinal disorder characterized by intestinal barrier dysfunction, gut microbiota dysbiosis, mitochondrial impairment, and mucosal immune imbalance. Mitochondrial quality control links epithelial energy metabolism, oxidative stress, mitophagy, inflammasome activation, and barrier homeostasis. Traditional Chinese medicine-derived bioactive compounds and natural products may provide multi-target regulatory advantages, yet the knowledge structure and translational trajectory remain unclear. Objective: This study aimed to map the landscape of mitochondrial quality control and intestinal barrier dysfunction in inflammatory bowel disease and clarify the translational potential of traditional Chinese medicine-derived bioactive compounds and natural products targeting mitochondrial-related mechanisms. Methods: Literature was retrieved from the Web of Science Core Collection and PubMed from January 1, 2000 to May 31, 2026. A two-stage bibliometric and knowledge-mapping analysis was conducted. Stage 1 focused on mitochondrial quality control and intestinal barrier dysfunction, whereas Stage 2 focused on traditional Chinese medicine-derived bioactive compounds and natural products targeting mitochondrial-related mechanisms. Publication trends, countries/regions, institutions, authors, journals, keywords, and co-cited references were analyzed. Results: Stage 1 identified 909 Web of Science Core Collection records and 741 PubMed records, with publication output increasing after 2020 and reaching 198 records in 2025. This field involved 51 countries/regions, 1,128 institutions, and 5,574 authors, with the United States, China, and Germany as leading contributors. Its intellectual base centered on NOD2/CARD15, ATG16L1, autophagy, Paneth cell dysfunction, antimicrobial peptide deficiency, oxidative phosphorylation, gut microbiota, and epithelial defense. Stage 2 expanded rapidly, increasing from 32 records in 2020 to 121 in 2025. This direction involved 42 countries/regions, 592 institutions, and 2,731 authors, with China occupying a dominant position. Research hotspots shifted from pharmacodynamic evaluation and experimental colitis models toward mitophagy, oxidative stress, NF-κB/NLRP3 inflammasome signaling, AMPK/mTOR signaling, SIRT1 activation, gut microbiota regulation, and barrier repair. Conclusion: Mitochondrial quality control is becoming a central framework for understanding inflammatory bowel disease. Current hotspots indicate a shift toward an integrated regulatory network involving mitochondria, immune responses, gut microbiota, and intestinal barrier function. Future frontiers should focus on causal validation of mitophagy-related pathways, identification of patient subgroups with abnormal mitochondrial quality control, and development of multi-target interventions to restore mucosal immune balance and barrier homeostasis. Traditional Chinese medicine-derived bioactive compounds and natural products may be valuable because their multi-pathway regulatory properties are consistent with the complex pathobiology of inflammatory bowel disease.

  • Open Access

    Metabolic profiles of amino acids in patients with crohn’s disease-associated perianal fistulas and cryptoglandular anal fistulas

    by Kai Ma, Cong Hu, Yi Fu, Yu Liu, Feiyang Weng, Yibo Yao, Chen Wang

    Crohn’s disease-associated perianal fistulas (PFCD) and Cryptoglandular anal fistulas (CAF) are two types of fistulas with similar clinical manifestations but distinct etiologies and therapeutic strategies. This study aims to investigate serum amino acid metabolic profiles in patients with CAF and PFCD based on UPLC-MS/MS. Serum samples were enrolled from newly diagnosed and treatment-naïve 36 patients with active PFCD and 36 patients with CAF as controls. Clinical characteristics were systematically documented. Serum concentrations of 25 amino acids were quantitatively determined using UPLC-MS/MS with isotopically labeled internal standards. Multivariate statistical analyses were employed to discriminate metabolic profiles between groups. Pathway enrichment analysis of differential amino acids was performed using Metabo Analyst 5.0. The PFCD cohort exhibited significantly lower total serum amino acid concentrations compared to CAF group, with 13 differentially expressed amino acids identified. Multivariate analyses revealed a significant separation trend between the two groups, eight amino acids were prioritized as candidate diagnostic biomarkers. Metabolic pathway enrichment analysis demonstrated that five pathways showed significant associations with metabolic disparities between the two groups. The proposed biomarker panel may assist in differentiating PFCD from CAF and guide individualized therapy.


  • Open Access

    Modified Ferguson hemorrhoidectomy for grade II–IV hemorrhoids offers low recurrence and complication rates: a retrospective cohort study

    by Run-Yi Geng, Lu Yin, Yong-Qing Cao, Xiao Shen, Ya-Qing Ding, Yi-Bo Yao, Chen Wang

    Purpose: This study aimed to evaluate the efficacy and safety of modified Ferguson hemorrhoidectomy (MFH) compared with conventional Milligan-Morgan hemorrhoidectomy (MMH) for grade II–IV hemorrhoids. Methods: A retrospective cohort of patients undergoing MFH or MMH between September 2020 and August 2021 was reviewed. The primary outcomes were healing time and recurrence after at least 24 months of follow-up. Secondary outcomes included Hemorrhoidal Disease Symptom Score (HDSS), postoperative complications, patient satisfaction, and quality-of-life assessment. Results: A total of 515 patients were enrolled (MFH, n = 254; MMH, n = 261) with a median follow-up of 29 months. The recurrence rate was significantly lower in the MFH group compared with MMH (1.2% vs. 5.0%, p = 0.013), with Kaplan–Meier analysis confirming superior recurrence-free survival (98.8% vs. 95.0% at 36 months). Healing time was shorter with MFH (26.3 ± 4.3 vs. 30.9 ± 3.5 days, p < 0.001). MFH reduced the risk of postoperative edema (2.4% vs. 9.6%, p = 0.01; OR 0.23, 95% CI 0.09–0.56) but showed a higher incidence of urinary retention (3.9% vs. 1.1%, p = 0.04). No anal stenosis or fecal incontinence was observed in either group. Patient satisfaction was higher in MFH (9.7 ± 0.7 vs. 9.4 ± 1.2, p = 0.002), and improvements in HDSS and SHSHD scores were sustained during long-term follow-up. Multivariate regression confirmed MFH as an independent protective factor against recurrence (adjusted OR 0.26, 95% CI 0.08–0.91, p = 0.035). Conclusion: Modified Ferguson hemorrhoidectomy is a safe and effective technique for grade II-IV hemorrhoids, offering lower recurrence, shorter healing, fewer complications, and higher satisfaction compared with Milligan-Morgan hemorrhoidectomy.

  • Open Access

    Shear Wave Elastography: Is the potential method in Assessing Anal Fistulas and Perianal Tissue strain?

    by Xiaochun Tao, Meng Hu, Haoqiang Yin, Jing Li, Jichun Si, Hongtao Liang, Chen Wang

    BACKGROUND Shear wave elastography, an ultrasound-based technique, has been widely used in China to assess tissue stiffness, but its application in perianal tissues remains limited. This study investigates its potential for diagnosing anal fistulas and evaluating perianal tissue characteristics. METHOD Between January 1st, 2022, and April 30th, 2023, shear wave elastography was performed in 152 patients with single-site simple anal fistulas to evaluate normal perianal tissue, fistula tissue, and postoperative scar tissue following lay-open surgery. Statistical analyses, including receiver operating characteristic (ROC) curve analysis and logistic regression, were employed to establish reference thresholds for differentiating among these tissue types. RESULTS Young’s modulus can serve as a key indicator for differentiating perianal tissues of different types, including normal tissue, fistula tissue, and scar tissue, and its values are not affected by sex, age, or BMI. However, the measurement location significantly influenced the results. When distinguishing normal tissue from fistula tissue, a measurement at the 7 ~ 5 o’clock position (lithotomy position) yielded a threshold of > 40.08 kPa for identifying fistula tissue (preset threshold = 0.45), whereas a measurement at the 5 ~ 7 o’clock position suggested fistula tissue at a threshold of > 54.95 kPa. For scar tissue, Young’s modulus was independent of measurement location, with values > 104.34 kPa indicating fistula tissue. CONCLUSION Shecar wave elastography shows potential for diagnosing anal fistulas, differentiating tissues of different types, and evaluating postoperative prognosis, enhancing diagnostic accuracy and providing a convenient tool for clinical assessment.

  • Open Access

    No manometric differences after surgical intervention for anal fistula in infants and toddlers

    by Yi Fu, Yu-Wen Ding, Yun-Yuan Li, Hong-Tao Liang, Yan-Ting Sun, Jin-Gen Lu, Chen Wang

    Background The current study aims to comprehensively evaluate the surgical impact on anal function in pediatric patients with anal fistulas, incorporating anorectal manometry, histopathological examination, and various rating scales. Methods The study focuses on infants and toddlers diagnosed with anal fistulas who underwent surgical intervention at Longhua Hospital, Shanghai University of Traditional Chinese Medicine, between November 2020 and January 2024. The participants were divided into two age cohorts: infants (0–12 months) and toddlers (13–36 months). Data were meticulously collected for both cohorts, with anal function assessed through intraoperative anorectal manometry, Masson staining of fistula tissue, and the Heikkinen clinical continence scoring (CCS) scale during the postoperative period Results (1) Both cohorts demonstrated a 100% postoperative healing rate. The average healing duration was 15.58 ± 3.21 days for the infant cohort and 16.57 ± 3.65 days for the toddler cohort. Anorectal manometry indicated the presence of the anorectal inhibitory reflex (RAIR) in both cohorts. Postfistulotomy, there was a slight decrease in anal rectal pressure (ARP), although this reduction was not statistically significant (p > 0.05) and was unrelated to the complexity of the fistula. Pathological examination of the fistula tissues revealed low muscle content in both cohorts, accounting for 14.1 ± 1.35% in the infant cohort and 17.2 ± 2.86% in the toddler cohort. The muscle composition varied between the cohorts; the infant cohort predominantly had smooth muscle with minimal striated muscle, whereas the toddler cohort had both smooth and striated muscle, with a relatively higher proportion of striated muscle. The CCS scores showed significant improvement at 6 months postoperation and during long-term follow-up compared to preoperative scores, with long-term follow-up results being superior to those at six months (p < 0.01). Conclusion Surgical treatment for pediatric anal fistulas demonstrates is both effective and safe, with a potential for long-term improvement in anorectal function over time.


  • Open Access

    Is Injectable Sclerotherapy with Polidocanol Foam Effective for Treating Hemorrhoids in Patients with Severe Anemia?

    by Yang Liu, Xiaochun Tao, Yingxin Fu, Chen Wang

    Objectives: The aim of this study was to evaluate the effectiveness of injectable sclerotherapy using Polidocanol foam in patients with hemorrhoids and severe anemia during a 1-year follow-up period, while utilizing the Hemorrhoidal Disease Severity Score (HDSS) in conjunction with Short Health Scale (SHS) for assessment.Methods: A retrospective analysis was conducted on patients with severe anemia and hemorrhoids who underwent injectable sclerotherapy using Polidocanol foam between February 2022 and May 2023.Results: The bleeding symptoms in all patients resolved immediately after treatment. Hemoglobin levels increased rapidly within one month after treatment, and statistically significant improvements were observed in HDSS score, and SHS score (P<0.001) during the one-year follow-up. Two patients experienced recurrence of prolapse symptoms during the one-year follow-up period and subsequently underwent hemorrhoidectomy.Conclusions: The use of Polidocanol foam in injectable sclerotherapy demonstrates highly promising effects in patients suffering from severe anemia caused by hemorrhoids.


  • Open Access

    Hongyuyin attenuates intestinal fibrosis in ulcerative colitis in mice revealed by transcriptomic and network pharmacology analyses

    by Qin Qin, Qingjun Dong, Yan Pan, Chen Wang, Jingen Lu

    Ulcerative colitis (UC) is a chronic, idiopathic inflammatory disease affecting the gastrointestinal tract. Hongyuyin (HYY), a traditional Chinese botanical formulation, has been effectively treating UC for over three decades; however, its underlying biological mechanism of action in UC-associated intestinal fibrosis (IF) remains unclear. This study investigated the mechanisms of action of HYY on IF through in vivo experiments using a dextran sulfate sodium (DSS)-induced mouse colitis model. Clinical symptoms, colonic pathological damage, inflammation, and fibrosis were monitored across all groups. Both transcriptomic analysis and network pharmacology (NP) techniques were utilized to elucidate the mechanistic insights. HYY treatment substantially reduced inflammation, fibroblast activation, and collagen deposition in UC mice. KEGG analyses suggested that HYY treatment modulated multiple signaling pathways, notably the TNF, IL-17, and PI3K-Akt signaling pathways. Combined analysis identified the PI3K-Akt signaling pathway as a major contributor, with high enrichment factors and numerous enrichment genes involved (IL-6, CSF3, SPP1, AKT1, PIK3CA, and so on) in UC-associated IF. Western blotting confirmed significant reductions in both p-AKT/AKT and p-mTOR/mTOR ratios after HYY treatment. Collectively, HYY alleviates UC-associated IF by reducing the phosphorylation of PI3K-Akt pathway factors, thereby inhibiting fibroblast activation and collagen deposition. This research provides novel insights into HYY’s mechanism of action in UC-associated IF management.

  • Open Access

    Rectal neuroendocrine tumor during anorectal surgery: three case reports and a review of the literature

    by Ruoxi Dong, Jingen Lu, Hao Zhou, Qingjun Dong, Chen Wang

    Background: Rectal neuroendocrine tumors (NET) are thought to originate from the diffuse neuroendocrine system. The lack of apparent signs of illness and the patient’s non-specific presentations often cause a delay in diagnosis, until in their final stages of cancer. Thus, rectal NETs pose a significant challenge to most physicians.Case presentation: This article presents three cases of rectal NETs discovered during anorectal surgery. Owing to their atypical symptoms, they were initially diagnosed as mixed hemorrhoids or perianal fistulas. However, the patients were diagnosed with rectal NETs and thus underwent endoscopic dissection or transanal endoscopic microsurgery. Histological analysis revealed three rectal NETs, one G1 and two G2. All patients were followed-up for more than 6 months, with excellent outcomes without recurrence.Conclusions: The etiology, pathogenesis, therapeutic methods, prevention, and prognosis of rectal NETs remain challenging. Given the variable understanding of the most appropriate operative approaches for rectal NETs, our objective was to broaden the perspective of this infrequent disease by delivering distinctive individual experiences and emphasizing the therapeutic significance of delicate surgery.


  • Open Access

    Genetic overlap between schizophrenia and constipation: insights from a genome-wide association study in a European population

    by Qinghua Luo, Mingwei An, Yunxiang Wu, Jiawen Wang, Yuanting Mao, Leichang Zhang, Chen Wang

    Patients with schizophrenia (SCZ) experience constipation at significantly higher rates compared with the general population. This relationship suggests a potential genetic overlap between these two conditions. We analyzed genome-wide association study (GWAS) data for both SCZ and constipation using a five-part approach. The first and second parts assessed the overall and local genetic correlations using methods such as linkage disequilibrium score regression (LDSC) and heritability estimation from summary statistics (HESS). The third part investigated the causal association between the two traits using Mendelian randomization (MR). The fourth part employed conditional/conjunctional false discovery rate (cond/conjFDR) to analyze the genetic overlap with different traits based on the statistical theory. Finally, an LDSC-specifically expressed gene (LDSC-SEG) analysis was conducted to explore the tissue-level associations. Our analyses revealed both overall and specific genetic correlations between SCZ and constipation at the genomic level. The MR analysis suggests a positive causal relationship between SCZ and constipation. The ConjFDR analysis confirms the genetic overlap between the two conditions and identifies two genetic risk loci (rs7583622 and rs842766) and seven mapped genes (GPR75-ASB3, ASB3, CHAC2, ERLEC1, GPR75, PSME4, and ACYP2). Further investigation into the functions of these genes could provide valuable insights. Interestingly, disease-related tissue analysis revealed associations between SCZ and constipation in eight brain regions (substantia nigra, anterior cingulate cortex, hypothalamus, cortex, hippocampus, cortex, amygdala, and spinal cord). This study provides the first genetic evidence for the comorbidity of SCZ and constipation, enhancing our understanding of the pathophysiology of both conditions.